Every year millions of cancer patients could be saved from prema­ture death and suffering if they had timely access to early detection and treatment.

World Health Organization

Onco­Lab Diag­nos­tics aims to contribute sub­stan­tially to enhanc­ing sur­vival time and qual­ity of life of can­cer patients and reduc­ing can­cer mor­tal­ity. We will achive this by devel­op­ing, man­u­fac­tur­ing and mar­ket­ing highly inno­v­a­tive and utmost pre­cise can­cer tests.

To achieve our goals we engage in research and devel­op­ment activ­i­ties in close coop­er­a­tion with renowned world­wide acad­e­mia and indus­try part­ners. Onco­lab Diag­nos­tics is ded­i­cated to research and devel­op­ment to find new means and tech­nolo­gies to diag­nose can­cer at much ear­lier stages.

OUR AMBITION: REDUCING THE CANCER BURDEN

Treatment alone will not win the war on cancer: prevention and early detection are crucial.

 WHO World Cancer Report 2014

 

Despite legions of researchers trying to find appropriate diag­nostic and curative measures, overall cancer mortality could not be reduced for decades. Cur­rently, there is an urgent need for reliable non-invasive diagnostic tools.

 

OncoLab Diagnostics combines its profound expertise in the field of cancer research with the ambition to improve the lives and outlook for cancer patients. 

INNOVATIVE TECHNOLOGIES

Uterine Lavage / NGS
Mutations in Uterine Lavage Fluid

Ultra-deep next generation sequencing detects pre-malignant or malignant cells in uterine lavage fluid specimens. The samples are collected by using our proprietory Speiser Catheter either in the operating room or at a physician's office. 

Liq­uid Biopsy
Circulating Tumour Cells

A new age of per­son­al­ized can­cer care begun with the intro­duc­tion of “Liq­uid Biopsy”, a blood test detect­ing can­cer in the cir­cu­la­tion and pro­vid­ing a non-​invasive pic­ture of a patient’s can­cer. It offers pos­si­ble post-​therapeutic sur­veil­lance of recurrence.

Blood biopsy diag­nos­tics is a mix of high-​tech tech­nol­ogy and cut­ting edge med­ical pro­ce­dures, and offers new ways for selec­tion of the right drug for the right patient at the right time — all through a sim­ple blood draw.

Blood-Based Testing
Immune Signature

Just a blood sam­ple is needed to see whether a per­son suf­fers from can­cer or not. Also the infor­ma­tion if a can­cer patient is respond­ing to a cer­tain ther­apy or if an alter­na­tive treat­ment should be cho­sen, can been derived from a sin­gle blood sample.

OUR CUTTING-EDGE PRODUCTS

Early Detec­tion of Cancer Tests

The early detection tests are applied to indi­vid­u­als who have a high risk to develop can­cer, e.g., due to a fam­ily his­tory or genetic pre­dis­po­si­tion.

Due to their out­stand­ing diag­nos­tic pre­ci­sion, these tests have high poten­tial to be used for population-​wide screen­ing in the long ​term.

LOC Test
Immune Signature Tests

Prognosis, Prediction and Monitoring Tests

These tests allow doctors to chose the most effi­cient treat­ment for their cancer patients. In addition, the tests will be designed to detect ther­apy fail­ures and/or can­cer recur­rence at an early statge which allows re-defining and adjusting the therapy in a timely manner.
The tests will be used to assess in real time whether the current therapy is effective or not. They will be applied at dif­fer­ent time points, namely before, dur­ing and after the ther­apy. When used in follow-​up sur­veil­lance after com­ple­tion of a  ther­apy, the monitoring tests even enable early detec­tion of a possible can­cer relapse.
Due to their non-​invasive nature and easy applic­a­bil­ity these blood tests rep­re­sent so-called ‘LIQ­UID BIOP­SIES’ which— unlike tis­sue biop­sies — can the­o­ret­i­cally be per­formed an unlim­ited num­ber of times.

CTC Tests

INNOVATION & EXPERTISE

The OncoLab team combines profound knowledge and expertise in tumour biology, oncology and international research projects. Besides the high scientific quality, the CEO of OncoLab has long-term experience in managing and operating diagnostics enterprises as well as in developing and marketing diagnostic tests.

read more

Contact us

OncoLab Diagnostics GmbH
Mahler­strasse 13
​1010 Vienna /​AUS­TRIA

office@​oncolab.​at

www​.dx4u​.at
www​.onco​lab​.at

Please enter your name.
Please enter a message.
Send
oncolab_logo_transparent_1246x281

OncoLab Diagnostics GmbH
Mahlerstrasse 13
1010 Vienna
Austria

© OncoLab Diagnostics GmbH, 2017